CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Chimerix Inc Company Snapshot
Chimerix Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Chimerix Inc with three other companies in this sector in the United States: Xoma Corporation (2016 sales of $5.56 million ), Apricus Biosciences Inc ($5.76 million ), and Sarepta Therapeutics Incorporated ($5.42 million of which 100% was Grants & Research).

Sales Analysis. Chimerix Inc reported sales of $5.70 million for the year ending December of 2016. This represents a sharp decrease of 47.0% versus 2015, when the company's sales were $10.76 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Chimerix Inc
  Stock Performance Chart for Chimerix Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 6.15
(Figures in U.S. Dollars)
1 Week -3.1%   13 Weeks 3.4%  
4 Weeks 29.5%   52 Weeks 18.0%  
 
Chimerix Inc Key Data:
  Ticker: CMRX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 5,702,000
(Year Ending Jan 2017).
Employees: 87
  Currency: U.S. Dollars Market Cap: 286,316,528
  Fiscal Yr Ends: December Shares Outstanding: 46,555,533
  Share Type: Common Closely Held Shares: 1,106,393
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.